Project Nightingale: Google probed over US patient data deal

INSUBCONTINENT EXCLUSIVE:
Image copyrightGetty ImagesImage caption Google's deal with Ascension, a major health firm, has attracted criticism from
some Google is to be investigated over how it is accessing US patient data via a major health firm, the Wall Street Journal
reports.An office of the US Department of Health and Human Services will examine the details of a deal dubbed "Project Nightingale".Google
said patient data was "secure".Separately, in the UK, the Financial Times (FT) reports that popular health websites are sharing sensitive
data with firms including Google.The Project Nightingale deal with Ascension - a firm that runs 2,600 hospitals in the US - attracted
criticism from some when the Wall Street Journal revealed that Google could access patient data without them being notified.Among those who
expressed concern was Republican Senator Lisa Murkowski."Privacy protections, particularly when it comes to personal info like your health,
is a high priority of mine," she said via Twitter.However, in a blog, Google argued that the deal "adheres to industry-wide regulations" and
that access to patient data by its employees was controlled.The tech giant said patient data would not be combined with customer data from
other parts of its business.It added that it was "happy to co-operate" with the federal inquiry.In its own blog, Ascension said it looked
forward to developing artificial intelligence tools for medical purposes with Google's help.News of Project Nightingale coincided with an FT
investigation that revealed how popular health websites in the UK frequently shared personal data with companies including Google, Amazon
and Facebook.Websites such as WebMD and Bupa used cookies - code added to web browsers - that allowed other companies to track users'
activity on the web.The kind of data shared from health websites to others included medical symptoms, diagnoses, and menstrual and fertility
information, as well as the names of drugs.Google told the FT it had strict policies preventing advertisers from using sensitive data to
target ads.